Trisha Suppes, MD, PhD

VA Palo Alto Health Care System and Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine, Palo Alto, California

  • 50Articles
  • 170.6KReads
  • 1997–2026Active
  • 129Collaborators
  • 831Citations

About

Trisha Suppes, MD, PhD, is affiliated with the VA Palo Alto Health Care System and the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. With over 50 articles published between 1997 and 2026, Suppes has contributed extensively to the study of bipolar disorder, major depressive disorder, mood disorders, and suicide. Her work covers clinical topics including patient care, child and adolescent psychiatry, and the therapeutic use of psychedelics. Frequent collaborators include Mark A. Frye, Susan L. McElroy, and Robert M. Post.

Publications

JCP
Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation
Original Research ▶ Video

Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation

May 13, 2026

A single psilocybin dose with psychological support was associated with rapid, large, and durable reductions in suicidal ideation and depressive symptoms.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

In Memoriam: Charles Bowden, MD, 1938–2022

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
Educational Activity

Maintenance Treatment for Bipolar Disorder

January 7, 2020

Guidelines lay out strategies for maintenance treatment of bipolar I disorder, with an algorithm for pharmacologic and psychosocial interventions. Dr Suppes describes guideline recommendations and situations when you might...
JCP
Educational Activity

Treating Acute Bipolar Mania

December 31, 2019

When should you rely on top-ranked treatment options for acute bipolar mania, and when should you skip down to lower-ranked options? In this brief CME activity, expert Dr Suppes...
JCP
Original Research

DSM-IV vs DSM-5: Effect on Bipolar Disorder Diagnosis

October 29, 2019

Since 2013, when DSM-5 was published, a third of the patients previously diagnosed with bipolar disorder no longer qualify as having the disorder. So what does this say about...
, , , et al
JCP
ASCP Corner

Depression with Mixed Features in MDD

January 30, 2018

Read an article describing depression with mixed features in Major Depressive Disorder (MDD) and the treatment of patients who meet the criteria.
,
JCP
Article

Florida Medication Guidelines for MDD

June 28, 2017

Do you need concise, pragmatic, evidence-based decision support for treating adults with MDD? In this CME activity, find updated guidelines that address medication choices as well as measurement-based care,...
, , , et al
JCP
Original Research

Age at Onset of Bipolar Disorder

October 26, 2016

Read this article to learn whether age of onset of bipolar disorder or psychiatric illness is due to demographics or family psychiatric history.
, , , et al
JCP
Original Research

Evidence of a Cohort Effect in Bipolar

August 24, 2016

Read an article exploring further evidence of the cohort effect for earlier age at onset of bipolar disorder and greater burden of psychiatric disorders.
, , , et al
JCP
Consensus Statement

Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians

July 27, 2016

, ,
JCP
Commentary

A Brief Commentary on the Bipolar CHOICE Study

January 27, 2016

PCC
Article

Illness Progression as a Function of Independent and Accumulating Poor Prognosis Factors in Outpatients With Bipolar Disorder in the United States

December 18, 2014

Many patients with bipolar disorder in the United States experience a deteriorating course of illness despite naturalistic treatment in the community. In this study, Post and colleagues explored this...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe